It has been demonstrated previously that activating α7nAChR played a protective effect in a variety of cardiovascular and cerebrovascular diseases, including TBI, ischemic stroke, ICH, SAH, hypertension and myocardial ischemia (43–45). Here, CHRNA7 is linked to myocardial ischemia.